• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    4.09 Down 0.08(1.92%) Apr 17, 4:00PM EDT
    |After Hours : 4.09 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:4.17
    Open:4.15
    Bid:3.96 x 2500
    Ask:N/A
    1y Target Est:10.00
    Beta:2.1
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:4.04 - 4.25
    52wk Range:1.56 - 4.25
    Volume:491,786
    Avg Vol (3m):978,686
    Market Cap:360.10M
    P/E (ttm):N/A
    EPS (ttm):-1.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RIGLDown 1.92%360.10M
    AMGNDown 1.97%124.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.91
    Quarterly EPS Est (Mar-15) :-0.18
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback